carbamazepine has been researched along with Anemia in 7 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To estimate the incidence of pancytopenia in patients taking leflunomide with or without methotrexate in Australia." | 7.74 | The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. ( Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG, 2007) |
| "To the best of our knowledge, this is the first published case report implicating carbamazepine as the cause of anemia associated with bone marrow hypercellularity and dyserythropoietic changes, instead of hypocellularity and reduction of erythroid precursors." | 7.70 | Severe multisystemic hypersensitivity reaction to carbamazepine including dyserythropoietic anemia. ( Corrocher, R; Girelli, DG; Lombardi, SM, 1999) |
| "Carbamazepine is gaining recognition as a valuable drug in the treatment of patients with bipolar disorders who fail to respond to lithium." | 7.67 | The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. ( Fawcett, J; Kravitz, HM, 1985) |
| "To estimate the incidence of pancytopenia in patients taking leflunomide with or without methotrexate in Australia." | 3.74 | The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. ( Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG, 2007) |
| "To the best of our knowledge, this is the first published case report implicating carbamazepine as the cause of anemia associated with bone marrow hypercellularity and dyserythropoietic changes, instead of hypocellularity and reduction of erythroid precursors." | 3.70 | Severe multisystemic hypersensitivity reaction to carbamazepine including dyserythropoietic anemia. ( Corrocher, R; Girelli, DG; Lombardi, SM, 1999) |
| "The purpose of this study was to determine the occurrence of leukopenia and other blood dyscrasias associated with psychiatric use of carbamazepine and valproate." | 3.69 | Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. ( Baldessarini, RJ; Castillo, J; Kando, JC; Tohen, M; Zarate, C, 1995) |
| "Carbamazepine is gaining recognition as a valuable drug in the treatment of patients with bipolar disorders who fail to respond to lithium." | 3.67 | The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. ( Fawcett, J; Kravitz, HM, 1985) |
| "Carbamazepine was found to cause statistically significant, but clinically insubstantial, decreases in white blood cell indexes." | 1.27 | Hematological effects of carbamazepine in patients with affective illness. ( Joffe, RT; Post, RM; Roy-Byrne, PP; Uhde, TW, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McEwen, J | 1 |
| Purcell, PM | 1 |
| Hill, RL | 1 |
| Calcino, LJ | 1 |
| Riley, CG | 1 |
| Hart, RG | 1 |
| Easton, JD | 1 |
| Tohen, M | 1 |
| Castillo, J | 1 |
| Baldessarini, RJ | 1 |
| Zarate, C | 1 |
| Kando, JC | 1 |
| Lombardi, SM | 1 |
| Girelli, DG | 1 |
| Corrocher, R | 1 |
| Hemingway, C | 1 |
| Leary, M | 1 |
| Riordan, G | 1 |
| Schlegal, B | 1 |
| Walker, K | 1 |
| Fawcett, J | 1 |
| Kravitz, HM | 1 |
| Joffe, RT | 1 |
| Post, RM | 1 |
| Roy-Byrne, PP | 1 |
| Uhde, TW | 1 |
7 other studies available for carbamazepine and Anemia
| Article | Year |
|---|---|
The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; An | 2007 |
Carbamazepine and hematological monitoring.
Topics: Adolescent; Anemia; Anemia, Aplastic; Carbamazepine; Female; Hematologic Diseases; Humans; Leukopeni | 1982 |
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk.
Topics: Adolescent; Adult; Anemia; Carbamazepine; Depressive Disorder; Desipramine; Drug Therapy, Combinatio | 1995 |
Severe multisystemic hypersensitivity reaction to carbamazepine including dyserythropoietic anemia.
Topics: Aged; Anemia; Anticonvulsants; Carbamazepine; Cell Size; Dermatitis, Exfoliative; Drug Hypersensitiv | 1999 |
The effect of carbamazepine and sodium valproate on the blood and serum values of children from a third-world environment.
Topics: Adolescent; Anemia; Anticonvulsants; Black People; Carbamazepine; Child; Child, Preschool; Developin | 1999 |
The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
Topics: Anemia; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination | 1985 |
Hematological effects of carbamazepine in patients with affective illness.
Topics: Adult; Anemia; Anemia, Aplastic; Bipolar Disorder; Carbamazepine; Diagnosis, Differential; Erythrocy | 1985 |